The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Lecap Asset Management Ltd.

Lecap Asset Management Ltd. grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 72.8% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,662 shares of the medical device company’s stock after purchasing an additional 8,707 shares during the period. Lecap Asset Management Ltd.’s holdings in Cooper Companies were worth $1,743,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD raised its stake in shares of Cooper Companies by 517.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company’s stock valued at $324,466,000 after acquiring an additional 2,957,421 shares in the last quarter. Norges Bank acquired a new stake in shares of Cooper Companies in the fourth quarter valued at $217,906,000. FMR LLC raised its stake in shares of Cooper Companies by 97.6% in the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company’s stock valued at $203,911,000 after acquiring an additional 1,095,805 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Cooper Companies in the fourth quarter valued at $64,826,000. Finally, Victory Capital Management Inc. raised its stake in shares of Cooper Companies by 14.6% in the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock valued at $415,985,000 after acquiring an additional 574,899 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $69.54 on Thursday. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The company has a market cap of $13.91 billion, a P/E ratio of 33.76, a PEG ratio of 1.73 and a beta of 0.98. The Cooper Companies, Inc. has a 52 week low of $65.00 and a 52 week high of $112.38. The company has a 50-day moving average price of $76.78 and a 200 day moving average price of $84.53.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. During the same period last year, the firm earned $0.85 EPS. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. Research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently commented on COO shares. Needham & Company LLC raised Cooper Companies from a “hold” rating to a “buy” rating and set a $94.00 target price on the stock in a report on Tuesday, June 17th. Wells Fargo & Company dropped their target price on Cooper Companies from $118.00 to $93.00 and set an “overweight” rating on the stock in a report on Friday, May 30th. Loop Capital set a $100.00 target price on Cooper Companies in a report on Tuesday, June 17th. Citigroup dropped their target price on Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Friday, March 7th. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and issued a $76.00 target price (down previously from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, Cooper Companies presently has a consensus rating of “Moderate Buy” and a consensus price target of $99.70.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.